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Introduction
Numerous studies have been conducted on the 
link between atherosclerosis and atherothrombotic 
events. The role of endothelium is to maintain vascu-
lar health. The endothelium modulates vascular flow 
by controlling vasodilator tonus, inhibiting platelet 
aggregation and  clotting factors, forming a barrier 
over the procoagulant subendothelial layer. Endo-
thelium also acts as a barrier against infamy and has 
the ability to self-repair in case of injury. 
Studies show that endothelial dysfunction is a 
predictor of the progression of atherosclerosis and 
acute coronary events in patients with or without 
known coronary disease.  Patients with diabetes have 
disorders in the coagulation system, which causes a 
hypercoagulable status [5].
About 70% of cases of acute coronary throm-
bosis involve the dislocation of an atherosclerotic 
plaque and 30% involve superficial lesions of the 
intima at the site of thrombus formation. Superficial 
endothelial lesions, which cause coronary thrombo-
sis, most commonly occur in women and diabetic 
patients with hypercholesterolemia. It is assumed 
that the cause of lesions would be the action of me-
talloproteinases in the subendothelial layer, which 
dislocates the endothelial cells from the basal lamina, 
causing desquamation. Up to 25% of endothelial 
erosions occur asymmetrically [4]. 
The systemic origin of endothelial dysfunction 
aggravates the process of atherosclerosis and con-
sequently occurs with acute coronary syndrome or 
chronic ischemic coronary heart disease.
PCI in the first hours of STEMI can be divided 
into primary PCI, PCI combined with reperfusion 
pharmacological therapy (PCI) and rescue PCI after 
failure of pharmacological reperfusion.  Primary PCI 
(balloon inflation) should be performed in all cases 
within the first two hours of first medical contact. 
Diabetic patients with angina pectoris symptoms 
should be screened by early coronary angiography, 
and primary PCI will be the preferred therapy in 
these patients. 
Clinical case
Patient D., aged 58 years, was urgently hos-
pitalized in the Cardiology Recovery Section on 
07.03.2017.
Accusation at admission. Retrosternal pain of 
constrictive character, irradiation in the shoulder 
and the left hand, present at rest, moderate intensity 
dyspnea, headache, dizziness, general weakness.
The history of the disease. He is considered ill 
for many years with HTA. It’s under the family doctor’s 
record. Outpatient treatment is irregularly adminis-
tered. In the last 3-4 days the state gradually worsens, 
presenting the above-mentioned accusations. On 
March 7, 2017, he requested the AMU service. He 
was urgently transported and hospitalized in the 
IMSP SCM Holy Trinity Hospital for the diagnosis and 
treatment tactics. 
Objective data: overall status of mean severity. 
Pink-pale skin. Rash is missing. Peripheral edema 
absent. Auscultatively throughout the lung area 
there is a vesicular murmur, missing rallies, FR = 18/
min. Apexian shock is determined in the intercostal 
space V with 1.5 cm lateral to the left medioclavicular 
line, 1.5 cm wide. Power and moderate resistance. 
Rhythmic, attenuated cardiac noises, FCC – 68 
beats/minute, TA – 140/80 mmHg. The abdomen 
is enlarged because of mass of adipose tissue and 
have soft palpation. No change in liver and spleen. 
Current intestinal transit. No pain during micturition. 
Negative Giordano sign bilateral. 
Paraclinic examination: hemoleucogram: 
hemoglobin – 166 g/l, erythrocyte – 5,1x1012/l, 
color index – 0,83, hematocrit – 43,4%, leukocyte – 
10,2x109/l, unshed – 8% – 3%, lymphocyte – 15%, 
monocyte – 8%, VSH – 24 mm/h.
Biochemical analisys: prothrombin – 119%, 
fibrinogen – 4.4 g/l, urea – 5.2 mmol/l, creatinine – 
0.09 mmol/l, glucose – 7.2 mmol/l, ALT – 139, AST 
– 116 u/l, total cholesterol – 6.2 mmol/l, triglyceride
– 2.30 mmol/l, potassium – 4.9 mmol/l, natrium –
147 mmol/l.
Echocardiographic examination: 13.03.2017 
– Induction of ascending Aortic Wall, VAo, VM. The
cavities of the heart are not dilated. Concentric hy-
pertrophy of the VS myocardium. The apical segment 
hypokinesia of the PPVS myocardium, the apical 
and middle segment of the PLVS myocardium. The 
pump function of the VS myocardium is sufficient. FE 
Simpson – 56%. Echo-CS Doppler: V max – N. Insuf-
ficient VM gr. I-II, VT gr. I-II, VAP gr. I. Impairment of 
relaxation of the VS myocardium.
Coronary angioplasty: tricoronaric atheroscle-
rotic lesions; occlusion through acute thrombosis on 
Cx I. Moderate stenosis on LAD II, RCA II.
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Angioplasty Protocol. Acute thrombosis occlu-
sion of Cx I is attempted. The common left artery co-
ronary artery is intubated with a 3.5-6F XB catheter. 
The lesion was traversed by a PILOT 50, 0.014 to the 
distal portion of the vessel. Pre-treatment with a 2.5-
20 mm SC swollen flask of 8 atm – 15 sec is practiced. 
Then implant the stent DES PROMUS 2.75-20 mm, 
inflated at 8 atm – 15 sec. The proximal segment of 
the stent was postdiluted with a balloon NC3.0 – 15 
mm, swollen at 14 atm 15 sec. There is a reduction 
in lesion score from 100% to 0 with TIMI III flow and 
good myocardial blash. Residual stenosis and dissec-
tions are not determined. Was’t compilation during 
the intervention. 
Clinical diagnosis
Tricoronaric atherosclerotic lesions. Occlusion 
through acute thrombosis on aCx I. Moderate ste-
nosis on LAD II, RCA II. Condition after PCI on aCx I 
(07.03.2017). Extremely high risk of high blood pre-
ssure. ICC II (NYHA), stage B ACC/AHA. Type II subcom-
pensated diabetes mellitus. Dyslipidemia.
aCx I before and after angioplasty
Stationary treatment
Tab. Cardiomagnyl – 75 mg, Tab. Plavix – 75 mg, 
Sol. Cardimac, Sol. Pyracetam, Tab. Mildronat – 500 
mg 2 daily. 
Conclusions
Patient D., aged 58 years, accusing retrosternal 
pain of constrictive character, irradiation in the sho-
ulder and the left hand, present and rest, moderate 
intensity dyspnea, headache, dizziness, general wea-
kness following a coronar angiography Established 
diagnosis: Tricoronary atherosclerotic lesions. Occlu-
sion through acute thrombosis on aCx I. Moderate 
stenosis on LAD II, RCA II. A stent was applied with 
revascularization of the respective region. The risk 
factors to which the patient is subjected, namely the 
presence of diabetes mellitus, HTA, irregular treat-
ment of ambulatory treatment, and dyslipidemia 
with 6.2 mmol/l cholesterol were determined from 
the biochemical analysis. SCORE score of 6%, which 
indicates a high risk of cardiovascular death over the 
next 10 years.
The patient is recommended to be registered 
with the family doctor, cardiologist, with dynamic 
monitoring of TA, glucose, lipid profile. Respecting 
the proper diet and a healthy lifestyle.
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